These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28394705)

  • 1. Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population.
    Akmatov MK; Riese P; May M; Jentsch L; Ahmed MW; Werner D; Rösel A; Tyler M; Pessler K; Prokein J; Bernemann I; Klopp N; Prochnow B; Trittel S; Tallam A; Illig T; Schindler C; Guzmán CA; Pessler F
    Hum Vaccin Immunother; 2017 Jul; 13(7):1630-1639. PubMed ID: 28394705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccination.
    Akmatov MK; Jentsch L; Riese P; May M; Ahmed MW; Werner D; Rösel A; Prokein J; Bernemann I; Klopp N; Prochnow B; Illig T; Schindler C; Guzman CA; Pessler F
    BMC Med Res Methodol; 2017 Feb; 17(1):18. PubMed ID: 28148221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    van Balveren-Slingerland L; Kant A; Härmark L
    Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367
    [No Abstract]   [Full Text] [Related]  

  • 4. A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.
    Moro ML; Nobilio L; Voci C; Di Mario S; Candela S; Magrini N;
    Vaccine; 2013 Feb; 31(10):1438-46. PubMed ID: 22885015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.
    Pérez-Romero P; Bulnes-Ramos A; Torre-Cisneros J; Gavaldá J; Aydillo TA; Moreno A; Montejo M; Fariñas MC; Carratalá J; Muñoz P; Blanes M; Fortún J; Suárez-Benjumea A; López-Medrano F; Barranco JL; Peghin M; Roca C; Lara R; Cordero E; ;
    Clin Microbiol Infect; 2015 Nov; 21(11):1040.e11-8. PubMed ID: 26232537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.
    Garg S; Thongcharoen P; Praphasiri P; Chitwarakorn A; Sathirapanya P; Fernandez S; Rungrojcharoenkit K; Chonwattana W; Mock PA; Sukwicha W; Katz JM; Widdowson MA; Curlin ME; Gibbons RV; Holtz TH; Dawood FS; Olsen SJ
    Clin Infect Dis; 2016 Feb; 62(3):383-391. PubMed ID: 26486702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of influenza vaccination among the elderly in Friuli-Venezia Giulia (Italy)].
    Valent F; Schiava F; Gnesutta D; Brianti G; Barbone F;
    Epidemiol Prev; 2005; 29(3-4):195-203. PubMed ID: 16454413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment.
    de Bekker-Grob EW; Veldwijk J; Jonker M; Donkers B; Huisman J; Buis S; Swait J; Lancsar E; Witteman CLM; Bonsel G; Bindels P
    Vaccine; 2018 Mar; 36(11):1467-1476. PubMed ID: 29426662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
    Pan SC; Kung HC; Kao TM; Wu H; Dong SX; Hu MH; Chou AH; Chong P; Hsieh SM; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):448-55. PubMed ID: 23022464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.
    Arnou R; Frank M; Hagel T; Prébet A
    Adv Ther; 2011 Jul; 28(7):555-65. PubMed ID: 21626269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.
    Roggelin L; Vinnemeier CD; Meyer S; Witte K; Marx L; Theeß W; Burchard GD; Rolling T; Cramer JP
    Hum Vaccin Immunother; 2015; 11(10):2370-5. PubMed ID: 26114800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of 3 seasonal trivalent influenza vaccines in the Chinese military.
    Gao D; Yang H; Deng B; Yin G; Song W; Zhang H; Li Y
    Hum Vaccin Immunother; 2016 Oct; 12(10):2634-2639. PubMed ID: 27348250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccination among the elderly in Italy.
    Pregliasco F; Sodano L; Mensi C; Selvaggi MT; Adamo B; D'Argenio P; Giussani F; Simonetti A; Carosella MR; Simeone R; Dentizi C; Montanaro C; Ponzio G
    Bull World Health Organ; 1999; 77(2):127-31. PubMed ID: 10083710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
    DiazGranados CA; Saway W; Gouaux J; Baron M; Baker J; Denis M; Jordanov E; Landolfi V; Yau E
    Vaccine; 2015 Dec; 33(51):7188-7193. PubMed ID: 26555348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.
    Blank PR; Schwenkglenks M; Szucs TD
    J Infect; 2009 Jun; 58(6):446-58. PubMed ID: 19446340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
    Rudenko L; Kiseleva I; Stukova M; Erofeeva M; Naykhin A; Donina S; Larionova N; Pisareva M; Krivitskaya V; Flores J;
    Vaccine; 2015 Sep; 33(39):5110-7. PubMed ID: 26296497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study.
    Carraro G; Naso A; Montomoli E; Gasparini R; Camerini R; Panatto D; Tineo MC; De Giorgi L; Piccirella S; Khadang B; Ceracchi M; De Rosa A
    Vaccine; 2012 Feb; 30(6):1170-80. PubMed ID: 22178096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Levin Y; Kochba E; Shukarev G; Rusch S; Herrera-Taracena G; van Damme P
    Vaccine; 2016 Oct; 34(44):5262-5272. PubMed ID: 27667332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influenza vaccination of elderly persons: state of the art].
    Pepersack T
    Rev Med Brux; 1999 Sep; 20(4):A321-4. PubMed ID: 10523916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.